We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
MDS Pharma Services Strengthens Therapeutic Focus on Respiratory and Metabolic Disorders
News

MDS Pharma Services Strengthens Therapeutic Focus on Respiratory and Metabolic Disorders

MDS Pharma Services Strengthens Therapeutic Focus on Respiratory and Metabolic Disorders
News

MDS Pharma Services Strengthens Therapeutic Focus on Respiratory and Metabolic Disorders

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "MDS Pharma Services Strengthens Therapeutic Focus on Respiratory and Metabolic Disorders"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

MDS Pharma Services has named two experienced medical professionals to lead its late stage clinical trial management activities related to respiratory ailments and metabolic disorders.

Dr. Bernard Tisserand and Dr. Jonny L. Salyer have been named Executive Medical Directors for Respiratory Disorders and Metabolic Disorders, respectively. These therapeutic areas represent serious global public health concerns and are key areas of focus for MDS Pharma Services' customers.

Respiratory disorders include conditions such as asthma, allergic rhinitis, chronic obstructive pulmonary disease (COPD), and community acquired pneumonia (CAP), while metabolic disorders include diabetes, dyslipidemia, obesity and metabolic syndrome, which are defined as a cluster of conditions that damage the cardiovascular system.

In addition to respiratory and metabolic disorders, other areas of therapeutic focus for MDS Pharma Services include oncology, vaccines, and diseases of the cardiovascular and central nervous systems.

Advertisement